Medicine Man Technologies Q1 2024 GAAP EPS $(0.24) Misses $(0.16) Estimate, Sales $41.601M Beat $39.834M Estimate
Medicine Man Technologies Q1 2024 GAAP EPS $(0.24) Misses $(0.16) Estimate, Sales $41.601M Beat $39.834M Estimate
Medicine Man Technologies 2024年第一季度公認會計准則每股收益美元（0.24）未達到預期（0.16）美元，銷售額4160.1萬美元超過3,9834萬美元的預期
Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.16) by 50 percent. This is a 300 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $41.601 million which beat the analyst consensus estimate of $39.834 million by 4.44 percent. This is a 4.00 percent increase over sales of $40.001 million the same period last year.
Medicine Man Technologies（場外交易代碼：SHWZ）公佈的季度虧損爲每股0.24美元，比分析師普遍預期的0.16美元（0.16美元）低50％。這比去年同期每股虧損0.06美元（0.06美元）下降了300％。該公司公佈的季度銷售額爲4160.1萬美元，比分析師普遍預期的3,983.4萬美元高出4.44％。這比去年同期的4,001萬美元銷售額增長了4.00％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。